quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 28, 2026

Montrose Environmental Group Q4 Earnings Call Highlights

View original at finance.yahoo.com
Montrose Environmental Group Q4 Earnings Call Highlights Montrose Environmental Group logo Key Points Montrose reported a "record" 2025 with revenue of $830.5 million and consolidated adjusted EBITDA of $116.2 million, and set 2026 guidance of $840–$900 million in revenue and $125–$130 million in adjusted EBITDA (imply…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Montrose is a water technology business with opportunities broader than PFAS

    80% confidence
  • PFAS-related revenue remains about 10% to 15% of the business, with double-digit growth expected into 2026

    80% confidence
  • 2025 was the strongest year in the company's history

    80% confidence
  • Company expects to generate approximately $180 million in cumulative operating cash flow across 2025 and 2026

    80% confidence
  • Recent U.S. EPA methane framework changes are not expected to have a material near-term impact on Montrose's services

    80% confidence
  • Fourth-quarter revenue rose to $193.3 million from $189.1 million a year earlier

    80% confidence
  • Quarterly margin decline attributed to lower margins in Measurement and Analysis and Remediation and Reuse, plus expenses tied to winding down renewables business

    80% confidence
  • M&A opportunities identified in testing and consulting across Australia, Canada, and the U.S.

    80% confidence
  • Water treatment total addressable market is more than $250 billion

    80% confidence
  • Company is targeting 60% operating cash conversion in 2026, above long-term 50%+ target

    80% confidence
  • Approximately 90% of Montrose's clients operate in private-sector industries and U.S. federal government exposure is less than 3% of revenue

    80% confidence
  • Remediation and Reuse margins expected to improve in 2026 as water treatment grows and operating leverage increases

    80% confidence
  • Measurement and Analysis margins expected to remain elevated though modestly lower than 2025

    80% confidence
  • Company expects APR segment margins to strengthen in 2026 due to demand, pricing discipline, and operational efficiency

    80% confidence
  • Organic growth of 12.7% exceeded long-term target of 7% to 9%

    80% confidence
  • No M&A deals appear imminent in Q1 or early Q2, with potential bolt-on activity more likely in back half of 2026

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Montrose Environmental Group Q4 Earnings Call Highlights — Source | Via News | pt.VIA.NEWS